| scholarly article | Q13442814 |
| P356 | DOI | 10.1017/S1041610211000688 |
| P698 | PubMed publication ID | 21489344 |
| P50 | author | Robert Balshaw | Q41048145 |
| Henry Brodaty | Q57570738 | ||
| P2093 | author name string | David Ames | |
| Michael Woodward | |||
| Karyn Boundy | |||
| PRIME Study Group | |||
| P2860 | cites work | “Mini-mental state” | Q25938989 |
| The Clinical Dementia Rating (CDR): current version and scoring rules | Q29616280 | ||
| Cognitive decline in incident Alzheimer disease in a community population | Q33763786 | ||
| MMSE scores decline at a greater rate in frontotemporal degeneration than in AD | Q35069613 | ||
| Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy | Q35767249 | ||
| Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment | Q35868499 | ||
| Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow up. | Q36242459 | ||
| Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology | Q36632771 | ||
| Predictors of progression of cognitive decline in Alzheimer's disease: the role of vascular and sociodemographic factors | Q37292162 | ||
| A national survey of memory clinics in Australia | Q37475150 | ||
| The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia | Q39605807 | ||
| The Neuropsychiatric Inventory: assessing psychopathology in dementia patients | Q41471895 | ||
| Rate of progression differs in frontotemporal dementia and Alzheimer disease. | Q45939864 | ||
| Rate of MMSE score change in Alzheimer's disease: influence of education and vascular risk factors | Q46226684 | ||
| Differentiating the frontal variant of Alzheimer's disease. | Q51889777 | ||
| Canadian Outcomes Study in Dementia: study methods and patient characteristics. | Q51937558 | ||
| Mild extrapyramidal signs and functional impairment in ageing. | Q51960341 | ||
| The Zarit Burden Interview: a new short version and screening version. | Q52017155 | ||
| Clock drawing in Alzheimer's disease. A novel measure of dementia severity. | Q52064819 | ||
| The Functional Autonomy Measurement System (SMAF): description and validation of an instrument for the measurement of handicaps. | Q52069303 | ||
| A new rating scale for Alzheimer's disease. | Q53197509 | ||
| The stress and psychological morbidity of the Alzheimer patient caregiver. | Q53230330 | ||
| Dementia with Lewy bodies | Q56059687 | ||
| Managing behavioural and psychological symptoms in dementia | Q78586858 | ||
| P433 | issue | 7 | |
| P304 | page(s) | 1086-1096 | |
| P577 | publication date | 2011-04-14 | |
| P1433 | published in | International Psychogeriatrics | Q15761572 |
| P1476 | title | Patients in Australian Memory Clinics: baseline characteristics and predictors of decline at six months | |
| P478 | volume | 23 |
| Q38380813 | A narrative review of evidence for the provision of memory services. |
| Q39621339 | Assessing people with dementia: the role of the aged care assessment team and memory clinics |
| Q93108441 | Assessing the Penetrance of Dementia Services |
| Q91845272 | Dementia and caregiver burden: A three-year longitudinal study |
| Q39079615 | Dietary Supplement Use in Older People Attending Memory Clinics in Australia |
| Q37193677 | Increased risk of cognitive impairment in patients with diabetes is associated with metformin |
| Q50572003 | Mild Cognitive Impairment and Driving Cessation: A 3-Year Longitudinal Study. |
| Q24187063 | Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI) |
| Q39545111 | Mortality in Mild Cognitive Impairment: A Longitudinal Study in Memory Clinics |
| Q92911062 | Neuropsychiatric symptoms as predictors of conversion from MCI to dementia: a machine learning approach |
| Q37632244 | Polypharmacy and inappropriate medication use in patients with dementia: an underresearched problem |
| Q40059162 | Potentially Inappropriate Medication, Anticholinergic Burden, and Mortality in People Attending Memory Clinics |
| Q40234322 | Potentially Inappropriate Medications and Anticholinergic Burden in Older People Attending Memory Clinics in Australia |
| Q39441648 | Predictors of Cognitive Decline in a Rural and Remote Saskatchewan Population With Alzheimer's Disease |
| Q39850196 | Predictors of Mortality in Dementia: The PRIME Study |
| Q46683884 | Progression from mild cognitive impairment to dementia: a 3-year longitudinal study |
| Q35693632 | Risk Factors for Progression of Alzheimer Disease in a Canadian Population: The Canadian Outcomes Study in Dementia (COSID). |
Search more.